Dahlöf B - Search Results

1

Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial.

Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J, Dahlöf B, de Faire U, Forsén K, Hedner T, Linjer E, Scherstén B, Wester P, Möller T. Lindholm LH, et al. Among authors: dahlof b. Lancet. 2001 Aug 18;358(9281):539-44. doi: 10.1016/s0140-6736(01)05704-x. Lancet. 2001. PMID: 11520524 Clinical Trial.

2

Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.

Dahlöf B, Herlitz H, Aurell M, Hansson L. Dahlöf B, et al. Am J Hypertens. 1992 Dec;5(12 Pt 1):900-11. doi: 10.1093/ajh/5.12.900. Am J Hypertens. 1992. PMID: 1337459 Clinical Trial.

3

Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.

Dahlöf B, Hansson L. Dahlöf B, et al. J Hypertens. 1992 Dec;10(12):1513-24. doi: 10.1097/00004872-199210120-00012. J Hypertens. 1992. PMID: 1338083 Clinical Trial.

4

Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO. Ekbom T, et al. Among authors: dahlof b. J Hypertens. 1992 Dec;10(12):1525-30. doi: 10.1097/00004872-199210120-00013. J Hypertens. 1992. PMID: 1338084 Clinical Trial.

5

The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure--insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Odén A, Scherstén B, Wester PO. Ekbom T, et al. Among authors: dahlof b. Blood Press. 1992 Oct;1(3):168-72. doi: 10.3109/08037059209077513. Blood Press. 1992. PMID: 1345050 Clinical Trial.

6

Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.

Dahlöf B, Stenkula S, Hansson L. Dahlöf B, et al. Blood Press. 1992 May;1(1):35-44. doi: 10.3109/08037059209065122. Blood Press. 1992. PMID: 1345141 Clinical Trial.

7

Regression of left ventricular hypertrophy--a meta-analysis.

Dahlöf B, Pennert K, Hansson L. Dahlöf B, et al. Clin Exp Hypertens A. 1992;14(1-2):173-80. doi: 10.3109/10641969209036180. Clin Exp Hypertens A. 1992. PMID: 1347256

8

Antihypertensive drugs and plasma lipids.

Hansson L, Dahlöf B. Hansson L, et al. Among authors: dahlof b. Br Heart J. 1992 May;67(5):421. doi: 10.1136/hrt.67.5.421-a. Br Heart J. 1992. PMID: 1356395 Free PMC article. Clinical Trial. No abstract available.

9

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point.

Hansson L, Hedner T, Dahlöf B. Hansson L, et al. Among authors: dahlof b. Blood Press. 1992 Aug;1(2):113-9. doi: 10.3109/08037059209077502. Blood Press. 1992. PMID: 1366259

10

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.

Dahlöf B, Pennert K, Hansson L. Dahlöf B, et al. Am J Hypertens. 1992 Feb;5(2):95-110. doi: 10.1093/ajh/5.2.95. Am J Hypertens. 1992. PMID: 1532319 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page